Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

The United States Government As Represented By The Department Of Veterans Affairs
The United States Government As Represented By The Department Of Veterans Affairs Department Of Vet

The United States Government As Represented By The Department Of Veterans Affairs patents


Recent patent applications related to The United States Government As Represented By The Department Of Veterans Affairs. The United States Government As Represented By The Department Of Veterans Affairs is listed as an Agent/Assignee. Note: The United States Government As Represented By The Department Of Veterans Affairs may have other listings under different names/spellings. We're not affiliated with The United States Government As Represented By The Department Of Veterans Affairs, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | The United States Government As Represented By The Department Of Veterans Affairs-related inventors


Treatment for hereditary neuropathy with liability to pressure palsies (hnpp)

A method of treating demyelinating diseases involves administering a PAK1 inhibitor that is PF-3758309 to a subject in need of such treatment.... The United States Government As Represented By The Department Of Veterans Affairs

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative diseases associated with abnormal accumulation of protein tau.... The United States Government As Represented By The Department Of Veterans Affairs

Novel methods, compounds, and compositions for anesthesia

Methods of treatment useful in the inducement or maintenance of anesthesia in a subject are provided. The methods comprise administering to a subject in need of anesthesia a compound disclosed herein. Also provided are novel compounds having anesthetic effects, pharmaceutical compositions comprising the compounds, and packaged pharmaceuticals. Computer modeling of... The United States Government As Represented By The Department Of Veterans Affairs

Compounds, compositions and associated methods comprising 3-aryl quinolines

Compounds, compositions and methods useful for treating infectious diseases are provided. In particular, 3-aryl quinoline compounds, their synthesis, pharmaceutical compositions thereof and methods of treating infectious diseases such as malaria, are disclosed.... The United States Government As Represented By The Department Of Veterans Affairs

Active stability devices and systems for mobile devices

A system for use with a mobile device includes at least one sensor to sense a variable related to tilting of the mobile device and at least one activatable system in operative connection with the sensor. The at least one activatable system increases stability of the mobile device upon actuation/change... The United States Government As Represented By The Department Of Veterans Affairs

Recombinant cd74 polypeptides

Disclosed are recombinant CD74 polypeptides mutated relative to the naturally occurring CD74 polypeptides with improved properties such as binding of CD74 ligands such as MIF and RTL1000 as well as polynucleotides that encode the polypeptides, expression vectors comprising the polynucleotides, bacteria that include the expression vectors, and methods of making... The United States Government As Represented By The Department Of Veterans Affairs

Methods and kits for assessing central nervous system integrity

The invention provides methods and kits for detecting, screening, quantifying or localizing the etiology for reduced or impaired cranial nerve function or conduction or associated cranial nucleus or supranuclear input, useful for detecting, diagnosing or screening for increased intracranial pressure, or useful for detecting, diagnosing, monitoring progression of or screening... The United States Government As Represented By The Department Of Veterans Affairs

Vmat inhibitory compounds

Disclosed herein are compounds that bind to the vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions comprising those compounds, and methods of treatment using said compounds and pharmaceutical compositions.... The United States Government As Represented By The Department Of Veterans Affairs

Multivalent fragments of antibody 3e10 and methods of use thereof

Antigen binding molecules that bind to the epitope of 3E10, and methods of use thereof are provided. The antigen binding molecule can include, for example, two or more variant single chain variable fragments (scFv) of monoclonal antibody 3E10, wherein the variant scFv has one or more insertions, deletions, or substitutions... The United States Government As Represented By The Department Of Veterans Affairs

Iron chelators and use thereof for reducing transplant failure during rejection episodes

... The United States Government As Represented By The Department Of Veterans Affairs

Aptamer-rnai therapeutic compositions

A recombinant nucleic acid comprising an aptamer that binds CD4 and an RNAi sequence that silences the expression of RORγ2 is described herein. Pharmaceutical compositions comprising the recombinant nucleic acid, particularly topical compositions are also described. Methods of treating inflammatory disease using the pharmaceutical composition are also described.... The United States Government As Represented By The Department Of Veterans Affairs

Amyotrophic lateral sclerosis (als) biomarkers and uses thereof

Provided herein are Amyotrophic lateral sclerosis (ALS) biomarkers and methods of using these ALS biomarkers to diagnose and treat ALS.... The United States Government As Represented By The Department Of Veterans Affairs

Recombinant t cell receptor ligand compositions and methods for treatment of prostate cancer

Disclosed herein are compositions and methods for treating or inhibiting prostate cancer. The compositions include a MHC molecule including covalently linked first and second domains, wherein the first domain is an MHC class II β1 domain and the second domain is an MHC class II α1 domain, wherein the amino... The United States Government As Represented By The Department Of Veterans Affairs

Recombinant t cell receptor ligand compositions and methods for treatment of prostate cancer

Disclosed herein are compositions and methods for treating or inhibiting prostate cancer. The compositions include a MHC molecule including covalently linked first and second domains, wherein the first domain is an MHC class II β1 domain and the second domain is an MHC class II α1 domain, wherein the amino... The United States Government As Represented By The Department Of Veterans Affairs

Desethylhydroxychloroquine for the treatment of diseases associated with inflammation

Compositions and methods are provided for inhibiting or treating the early and established stages of inflammatory diseases by administration of an effective dose of the desethylhydroxychloroquine (DHCQ). A benefit of the methods is the ability to deliver a dose of agent that is effective in treating inflammation while sparing the... The United States Government As Represented By The Department Of Veterans Affairs

Vault complexes for cytokine delivery

The invention relates to compositions of vault complexes containing recombinant cytokine fusion proteins that include a cytokine and a vault targeting domain, and methods of using the vault complexes to deliver the cytokines to a cell or subject, and methods for using the compositions to treat cancer, such as lung... The United States Government As Represented By The Department Of Veterans Affairs

Compounds that bind macrophage migration inhibitory factor

Recombinant polypeptides, pharmaceutical compositions comprising recombinant polypeptides, and methods of treating autoimmune and/or inflammatory diseases using the pharmaceutical compositions are disclosed. The polypeptides are based upon the trimerization and/or MIF binding domains of CD74.... The United States Government As Represented By The Department Of Veterans Affairs

Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism

The present invention relates to the reduction of a symptom of an alcohol withdrawal state comprising administering a modulator of histone acetylation.... The United States Government As Represented By The Department Of Veterans Affairs

Methods and compositions for vein harvest and autografting

The leading cause of graft failure is the subsequent development of intimal hyperplasia, which represents a response to injury that is thought to involve smooth muscle proliferation, migration, phenotypic modulation, and extracellular matrix (ECM) deposition. Surgical techniques typically employed for vein harvest—stretching the vein, placing the vein in low pH,... The United States Government As Represented By The Department Of Veterans Affairs

Compounds and compositions for ossification and methods related thereto

The disclosure relates to compounds and compositions for forming bone and methods related thereto. In one embodiment, the disclosure relates to a composition comprising a compound disclosed herein, such as 2,4-diamino-1,3,5-triazine derivatives or salts thereof, for use in bone growth processes. In a typical embodiment, a bone graft composition is... The United States Government As Represented By The Department Of Veterans Affairs

Novel hydrogel tissue expanders

The present invention provides tissue expanders comprising biodegradable, chemically cross-linked hydrogels which are elastic in the dry state. These biocompatible tissue expanders are self-inflating and membrane-free. They swell slowly and elicit minimal negative tissue responses, while allowing for rapid and easy manipulation by the surgeon at the time of emplacement.... The United States Government As Represented By The Department Of Veterans Affairs

Methods for producing an immune response to tuberculosis

Methods for producing an immune response to Mycobacterium tuberculosis (Mtb) are disclosed herein. In several examples, the immune response is a protective immune response. In additional embodiments, methods are disclosed for inhibiting an infection with Mtb, preventing an infection with Mtb, or treating an infection with Mtb. Pharmaceutical compositions for... The United States Government As Represented By The Department Of Veterans Affairs

Methods for producing an immune response to tuberculosis

Methods for producing an immune response to Mycobacterium tuberculosis (Mtb) are disclosed herein. In several examples, the immune response is a protective immune response. In additional embodiments, methods are disclosed for inhibiting an infection with Mtb, preventing an infection with Mtb, or treating an infection with Mtb. Pharmaceutical compositions for... The United States Government As Represented By The Department Of Veterans Affairs

Quinolone-3-diarylethers

Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.... The United States Government As Represented By The Department Of Veterans Affairs

Methods and compositions used in treating inflammatory and autoimmune diseases

Methods of treating neuroinflammation by administration of a selective protein C activator, such as recombinant human WE thrombin and optionally one or more of its cofactors are disclosed. Also disclosed are pharmaceutical compositions for use in the treatment of mammals that exhibit symptoms of neurological inflammation. The pharmaceutical compositions and... The United States Government As Represented By The Department Of Veterans Affairs








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with The United States Government As Represented By The Department Of Veterans Affairs in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for The United States Government As Represented By The Department Of Veterans Affairs with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###